NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky is investigating the Board of Directors of Cornerstone Therapeutics, Inc. (“Cornerstone” or the “Company”) (Nasdaq: CRTX) for possible breaches of fiduciary duty and other violations of state law in connection with a going private proposal from Chiesi Farmaceutici SpA (“Chiesi”). Chiesi owns approximately 60% of the outstanding shares of the Company's common stock.
Click here to learn how to join the action: http://zlk.9nl.com/cornerstone-therapeutics-crtx/, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the proposed transaction, Cornerstone shareholders would receive between $6.40 and $6.70 for each share of Cornerstone stock they own. The investigation concerns, among other things, whether the proposed consideration to be paid to Cornerstone shareholders is unfair, inadequate, and substantially below the fair or inherent value of Cornerstone stock. In particular, at least one analyst set a price target for Cornerstone stock at $14.00 per share.
If you own common stock in Cornerstone and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or http://zlk.9nl.com/cornerstone-therapeutics-crtx/.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.